The following information appeared on, CMS.gov
Effective for claims with dates of service on and after April 13, 2021, CMS will nationally cover autologous PRP for the treatment of chronic non-healing diabetic wounds under Section 1862(a)(1)(A) of the Social Security Act (the Act) for a duration of 20 weeks. This applies when using devices whose FDA-cleared indications include the management of exuding cutaneous wounds, such as diabetic ulcers.
